Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Dec;28(6):621–628. doi: 10.1111/j.1365-2125.1989.tb03554.x

The effects of food on drug bioavailability.

P A Winstanley 1, M L Orme 1
PMCID: PMC1380032  PMID: 2692684

Full text

PDF
624

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelson J. E., Chan G. L., Kirsten E. B., Mason W. D., Lanman R. C., Kerr C. R. Food increases the bioavailability of propafenone. Br J Clin Pharmacol. 1987 Jun;23(6):735–741. doi: 10.1111/j.1365-2125.1987.tb03109.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BRANDT J. L., CASTLEMAN L., RUSKIN H. D., GREENWALD J., KELLY J. J., Jr The effect of oral protein and glucose feeding of splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects. J Clin Invest. 1955 Jul;34(7 Pt 1):1017–1025. doi: 10.1172/JCI103151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barbhaiya R. H., Craig W. A., Corrick-West H. P., Welling P. G. Pharmacokinetics of hydrochlorothiazide in fasted and nonfasted subjects: a comparison of plasma level and urinary excretion methods. J Pharm Sci. 1982 Feb;71(2):245–248. doi: 10.1002/jps.2600710226. [DOI] [PubMed] [Google Scholar]
  4. Bates T. R., Gibaldi M., Kanig J. L. Solubilizing properties of bile salt solutions. I. Effect of temperature and bile salt concentration on solubilization of glutethimide, griseofulvin, and hexestrol. J Pharm Sci. 1966 Feb;55(2):191–199. doi: 10.1002/jps.2600550213. [DOI] [PubMed] [Google Scholar]
  5. Beermann B., Groschinsky-grind M. Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug. Eur J Clin Pharmacol. 1978 May 31;13(3):195–201. doi: 10.1007/BF00609982. [DOI] [PubMed] [Google Scholar]
  6. Bianchine J. R., Shaw G. M. Clinical pharmacokinetics of levodopa in parkinson's disease. Clin Pharmacokinet. 1976;1(5):313–338. doi: 10.2165/00003088-197601050-00001. [DOI] [PubMed] [Google Scholar]
  7. Bogentoft C., Carlsson I., Ekenved G., Magnusson A. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. Eur J Clin Pharmacol. 1978 Dec 18;14(5):351–355. doi: 10.1007/BF00611905. [DOI] [PubMed] [Google Scholar]
  8. CRONK G. A., WHEATLEY W. B., FELLERS G. F., ALBRIGHT H. The relationship of food intake to the absorption of potassium alpha-phenoxyethyl penicillin and potassium phenoxymethyl penicillin from the gastrointestinal tract. Am J Med Sci. 1960 Aug;240:219–225. [PubMed] [Google Scholar]
  9. Conney A. H., Pantuck E. J., Hsiao K. C., Garland W. A., Anderson K. E., Alvares A. P., Kappas A. Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clin Pharmacol Ther. 1976 Dec;20(6):633–642. doi: 10.1002/cpt1976206633. [DOI] [PubMed] [Google Scholar]
  10. Coulter J. B., Lamplugh S. M., Suliman G. I., Omer M. I., Hendrickse R. G. Aflatoxins in human breast milk. Ann Trop Paediatr. 1984 Jun;4(2):61–66. doi: 10.1080/02724936.1984.11748311. [DOI] [PubMed] [Google Scholar]
  11. Daneshmend T. K., Roberts C. J. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol. Br J Clin Pharmacol. 1982 Jul;14(1):73–78. doi: 10.1111/j.1365-2125.1982.tb04936.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Disler P. B., Lynch S. R., Charlton R. W., Torrance J. D., Bothwell T. H., Walker R. B., Mayet F. The effect of tea on iron absorption. Gut. 1975 Mar;16(3):193–200. doi: 10.1136/gut.16.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Drasar B. S., Shiner M., McLeod G. M. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology. 1969 Jan;56(1):71–79. [PubMed] [Google Scholar]
  14. Edwards G., Breckenridge A. M. Clinical pharmacokinetics of anthelmintic drugs. Clin Pharmacokinet. 1988 Aug;15(2):67–93. doi: 10.2165/00003088-198815020-00001. [DOI] [PubMed] [Google Scholar]
  15. Fagan T. C., Walle T., Oexmann M. J., Walle U. K., Bai S. A., Gaffney T. E. Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet. Clin Pharmacol Ther. 1987 Apr;41(4):402–406. doi: 10.1038/clpt.1987.48. [DOI] [PubMed] [Google Scholar]
  16. George C. F. Food, drugs, and bioavailability. Br Med J (Clin Res Ed) 1984 Oct 27;289(6452):1093–1094. doi: 10.1136/bmj.289.6452.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Golub A. L., Frost R. W., Betlach C. J., Gonzalez M. A. Physiologic considerations in drug absorption from the gastrointestinal tract. J Allergy Clin Immunol. 1986 Oct;78(4 Pt 2):689–694. doi: 10.1016/0091-6749(86)90047-3. [DOI] [PubMed] [Google Scholar]
  18. Greenblatt D. J., Allen M. D., MacLaughlin D. S., Harmatz J. S., Shader R. I. Diazepam absorption: effect of antacids and food. Clin Pharmacol Ther. 1978 Nov;24(5):600–609. doi: 10.1002/cpt1978245600. [DOI] [PubMed] [Google Scholar]
  19. Hamann S. R., Blouin R. A., McAllister R. G., Jr Clinical pharmacokinetics of verapamil. Clin Pharmacokinet. 1984 Jan-Feb;9(1):26–41. doi: 10.2165/00003088-198409010-00002. [DOI] [PubMed] [Google Scholar]
  20. Haynes R. B., Sackett D. L., Gibson E. S., Taylor D. W., Hackett B. C., Roberts R. S., Johnson A. L. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976 Jun 12;1(7972):1265–1268. doi: 10.1016/s0140-6736(76)91737-2. [DOI] [PubMed] [Google Scholar]
  21. Horton R. J. Introduction of halofantrine for malaria treatment. Parasitol Today. 1988 Sep;4(9):238–239. doi: 10.1016/0169-4758(88)90136-6. [DOI] [PubMed] [Google Scholar]
  22. Ishizaki T., Nomura T., Abe T. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man. J Pharmacokinet Biopharm. 1979 Aug;7(4):369–381. doi: 10.1007/BF01062535. [DOI] [PubMed] [Google Scholar]
  23. Jordan M. C., de Maine J. B., Kirby W. M. Clinical pharmacology of pivampicillin as compared with ampicillin. Antimicrob Agents Chemother (Bethesda) 1970;10:438–441. [PubMed] [Google Scholar]
  24. McCracken G. H., Jr, Ginsburg C. M., Clahsen J. C., Thomas M. L. Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability. Pediatrics. 1978 Nov;62(5):738–743. [PubMed] [Google Scholar]
  25. Melander A., Brante G., Johansson O., Lindberg T., Wåhlin-Boll E. Influence of food on the absorption of phenytoin in man. Eur J Clin Pharmacol. 1979 May 21;15(4):269–274. doi: 10.1007/BF00618516. [DOI] [PubMed] [Google Scholar]
  26. Melander A., Danielson K., Hanson A., Jansson L., Rerup J. C., Scherstén B., Thulin T., Wåhlin E. Reduction of isoniazid bioavailability in normal men by concomitant intake of food. Acta Med Scand. 1976;200(1-2):93–97. doi: 10.1111/j.0954-6820.1976.tb08202.x. [DOI] [PubMed] [Google Scholar]
  27. Melander A., Danielson K., Hanson A., Rudell B., Scherstén B., Thulin T., Wåhlin E. Enhancement of hydralazine bioavailability by food. Clin Pharmacol Ther. 1977 Jul;22(1):104–107. doi: 10.1002/cpt1977221104. [DOI] [PubMed] [Google Scholar]
  28. Melander A., Danielson K., Scherstén B., Wåhlin E. Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther. 1977 Jul;22(1):108–112. doi: 10.1002/cpt1977221108. [DOI] [PubMed] [Google Scholar]
  29. Melander A. Influence of food on the bioavailability of drugs. Clin Pharmacokinet. 1978 Sep-Oct;3(5):337–351. doi: 10.2165/00003088-197803050-00001. [DOI] [PubMed] [Google Scholar]
  30. Melander A., Lalka D., McLean A. Influence of food on the presystemic metabolism of drugs. Pharmacol Ther. 1988;38(2):253–267. doi: 10.1016/0163-7258(88)90099-x. [DOI] [PubMed] [Google Scholar]
  31. Melander A., McLean A. Influence of food intake on presystemic clearance of drugs. Clin Pharmacokinet. 1983 Jul-Aug;8(4):286–296. doi: 10.2165/00003088-198308040-00002. [DOI] [PubMed] [Google Scholar]
  32. Melander A., Stenberg P., Liedholm H., Scherstén B., Wåhlin-Boll E. Food-induced reduction in bioavailability of atenolol. Eur J Clin Pharmacol. 1979 Nov;16(5):327–330. doi: 10.1007/BF00605630. [DOI] [PubMed] [Google Scholar]
  33. Melander A., Wåhlin E. Enhancement of dicoumarol bioavailability by concomitant food intake. Eur J Clin Pharmacol. 1978 Dec 18;14(6):441–444. doi: 10.1007/BF00716387. [DOI] [PubMed] [Google Scholar]
  34. Michiels M., Hendriks R., Heykants J., van den Bossche H. The pharmacokinetics of mebendazole and flubendazole in animals and man. Arch Int Pharmacodyn Ther. 1982 Apr;256(2):180–191. [PubMed] [Google Scholar]
  35. Milton K. A., Edwards G., Ward S. A., Orme M. L., Breckenridge A. M. Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol. 1989 Jul;28(1):71–77. doi: 10.1111/j.1365-2125.1989.tb03507.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Männistö P. T., Mäntylä R., Nykänen S., Lamminsivu U., Ottoila P. Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother. 1982 May;21(5):730–733. doi: 10.1128/aac.21.5.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Neuman M. Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Clin Pharmacokinet. 1988 Feb;14(2):96–121. doi: 10.2165/00003088-198814020-00003. [DOI] [PubMed] [Google Scholar]
  38. Neuvonen P. J. Interactions with the absorption of tetracyclines. Drugs. 1976;11(1):45–54. doi: 10.2165/00003495-197611010-00004. [DOI] [PubMed] [Google Scholar]
  39. Palma R., Vidon N., Houin G., Pfeiffer A., Rongier M., Barre J., Bernier J. J. Influence of bile salts and lipids on intestinal absorption of griseofulvin in man. Eur J Clin Pharmacol. 1986;31(3):319–325. doi: 10.1007/BF00981131. [DOI] [PubMed] [Google Scholar]
  40. Pantuck E. J., Hsiao K. C., Conney A. H., Garland W. A., Kappas A., Anderson K. E., Alvares A. P. Effect of charcoal-broiled beef on phenacetin metabolism in man. Science. 1976 Dec 3;194(4269):1055–1057. doi: 10.1126/science.982059. [DOI] [PubMed] [Google Scholar]
  41. Pantuck E. J., Pantuck C. B., Anderson K. E., Wattenberg L. W., Conney A. H., Kappas A. Effect of brussels sprouts and cabbage on drug conjugation. Clin Pharmacol Ther. 1984 Feb;35(2):161–169. doi: 10.1038/clpt.1984.22. [DOI] [PubMed] [Google Scholar]
  42. Pantuck E. J., Pantuck C. B., Garland W. A., Min B. H., Wattenberg L. W., Anderson K. E., Kappas A., Conney A. H. Stimulatory effect of brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther. 1979 Jan;25(1):88–95. doi: 10.1002/cpt197925188. [DOI] [PubMed] [Google Scholar]
  43. Polasa K., Krishnaswamy K. Effect of food on bioavailability of rifampicin. J Clin Pharmacol. 1983 Oct;23(10):433–437. doi: 10.1002/j.1552-4604.1983.tb01787.x. [DOI] [PubMed] [Google Scholar]
  44. Rajpurohit R., Krishnaswamy K. Differences in response of glucuronide and glutathione conjugating enzymes to aflatoxin B1 and N-acetylaminofluorene in underfed rats. J Toxicol Environ Health. 1988;24(1):103–109. doi: 10.1080/15287398809531143. [DOI] [PubMed] [Google Scholar]
  45. Rosenberg H. A., Bates T. R. The influence of food on nitrofurantoin bioavailability. Clin Pharmacol Ther. 1976 Aug;20(2):227–232. doi: 10.1002/cpt1976202227. [DOI] [PubMed] [Google Scholar]
  46. Routledge P. A., Chapman P. H., Davies D. M., Rawlins M. D. Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol. 1979 Jun 12;15(5):319–322. doi: 10.1007/BF00558434. [DOI] [PubMed] [Google Scholar]
  47. Routledge P. A. The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing. Br J Clin Pharmacol. 1988 Oct;26(4):339–345. doi: 10.1111/j.1365-2125.1988.tb03390.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Santodonato J., Howard P., Basu D. Health and ecological assessment of polynuclear aromatic hydrocarbons. J Environ Pathol Toxicol. 1981 Sep;5(1):1–364. [PubMed] [Google Scholar]
  49. Sartor G., Lundquist I., Melander A., Scherstén B., Wåhlin-Boll E. Improved effect of glibenclamide on administration before breakfast. Eur J Clin Pharmacol. 1982;21(5):403–408. doi: 10.1007/BF00542327. [DOI] [PubMed] [Google Scholar]
  50. Schuna A., Osman M. A., Patel R. B., Welling P. G., Sundstrom W. R. Influence of food on the bioavailability of penicillamine. J Rheumatol. 1983 Feb;10(1):95–97. [PubMed] [Google Scholar]
  51. Siegel D. Tetracyclines: new look at old antibiotic. II. Clinical use. N Y State J Med. 1978 Jun;78(7):1115–1120. [PubMed] [Google Scholar]
  52. Singhvi S. M., McKinstry D. N., Shaw J. M., Willard D. A., Migdalof B. H. Effect of food on the bioavailability of captopril in healthy subjects. J Clin Pharmacol. 1982 Feb-Mar;22(2-3):135–140. doi: 10.1002/j.1552-4604.1982.tb02661.x. [DOI] [PubMed] [Google Scholar]
  53. Ther L., Winne D. Drug absorption. Annu Rev Pharmacol. 1971;11:57–70. doi: 10.1146/annurev.pa.11.040171.000421. [DOI] [PubMed] [Google Scholar]
  54. Walter-Sack I. The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption. Klin Wochenschr. 1987 Oct 1;65(19):927–935. doi: 10.1007/BF01745506. [DOI] [PubMed] [Google Scholar]
  55. Walter-Sack I. The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion. Klin Wochenschr. 1987 Nov 2;65(21):1062–1072. doi: 10.1007/BF01726326. [DOI] [PubMed] [Google Scholar]
  56. Welling P. G., Huang H., Koch P. A., Craig W. A., Madsen P. O. Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects. J Pharm Sci. 1977 Apr;66(4):549–552. doi: 10.1002/jps.2600660423. [DOI] [PubMed] [Google Scholar]
  57. Welling P. G. Influence of food and diet on gastrointestinal drug absorption: a review. J Pharmacokinet Biopharm. 1977 Aug;5(4):291–334. doi: 10.1007/BF01061694. [DOI] [PubMed] [Google Scholar]
  58. Welling P. G. Interactions affecting drug absorption. Clin Pharmacokinet. 1984 Sep-Oct;9(5):404–434. doi: 10.2165/00003088-198409050-00002. [DOI] [PubMed] [Google Scholar]
  59. Willis J. V., Jack D. B., Kendall M. J., John V. A. The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration. Eur J Clin Pharmacol. 1981 Jan;19(1):39–44. doi: 10.1007/BF00558382. [DOI] [PubMed] [Google Scholar]
  60. Woodcock B. G., Kraemer N., Rietbrock N. Effect of a high protein meal on the bioavailability of verapamil. Br J Clin Pharmacol. 1986 Mar;21(3):337–338. doi: 10.1111/j.1365-2125.1986.tb05202.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wåhlin-Boll E., Melander A., Sartor G., Scherstén B. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects. Eur J Clin Pharmacol. 1980 Oct;18(3):279–283. doi: 10.1007/BF00563012. [DOI] [PubMed] [Google Scholar]
  62. von Philipsborn G., Gries J., Hofmann H. P., Kreiskott H., Kretzschmar R., Müller C. D., Raschack M., Teschendorf H. J. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone. Arzneimittelforschung. 1984;34(11):1489–1497. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES